Pressroom: Media Coverage

Showing 301 - 320 of 555 news items


Nanotechnology May Aid Diagnosis

Biochemist Yueming Li commented on new technology that is three million times more sensitive at detecting Alzheimer’s disease and certain cancers.

July 10, 2012
Esophageal Cancer Is the Fastest Growing Cancer in the US

Thoracic surgeon Manjit Bains and Memorial Sloan Kettering patient Bart Frazzitta were interviewed about esophageal cancer.

July 6, 2012
Wallaby and Cancer-Free

Tarrytown resident and Memorial Sloan Kettering patient Sharai Platt joined more than 200 cancer survivors at Memorial Sloan Kettering in Sleepy Hollow, NY, to observe National Cancer Survivors Day.

July 5, 2012
Prostate Surgery Tied to Need for Bladder Surgery

Department of Surgery Chair Peter Scardino commented on a study that found that one in 20 men who have their prostate gland removed may need a second surgery for severe loss of bladder control. Dr. Scardino said the finding further confirms the need for patients to choose surgeons and medical centers with deep experience in treating prostate cancer.

June 29, 2012
Two-thirds of New Yorkers Survive Cancer

Breast Cancer Medicine Service Chief Clifford Hudis commented on new health data that found that two out of three cancer patients are surviving the disease today, compared to just half three decades ago.

June 25, 2012
Ask a Best Doctor: The Death Trap of Sitting, Soy Milk vs. Skim, and Decoding Panic Attacks

Gastroenterology and Nutrition Service Chief Robert Kurtz discussed the differences between soy milk and skim milk. He said both are pretty much the same, nutritionally, but soy milk contains plant-based phyto-estrogens, which act much the same way in the body that estrogen does. Many believe that soy milk could, theoretically, cause a hormone disruption due to the effect of the phyto-estrogens, but there is no hard evidence to show that drinking soy milk poses any dangers.

June 22, 2012
Indoor Tanners Rationalize Risky Behavior, Study Finds

Behavioral scientist Smita Banerjee led a study of 500 US college students and found that almost 40 percent use tanning beds even though they’re aware of the cancer risks associated with ultraviolet light exposure, and that most do it because they want to look more attractive. Dr. Banerjee also discussed her study in

June 20, 2012
Actress Kathy Bates Beat Ovarian Cancer

Academy Award–winning actress and ovarian cancer survivor Kathy Bates spoke at Memorial Sloan Kettering in observance of National Cancer Survivors Day.

June 17, 2012
Rye Resident Celebrates Post-Cancer Life

Cancer survivors from Memorial Sloan Kettering gathered in observance of National Cancer Survivors Day to celebrate milestones in their cancer journey. Events were held at Memorial Sloan Kettering’s New York and suburban outpatient treatment centers throughout June. Several local outlets covered the events, including Rye Patch and Basking Ridge Patch.

June 15, 2012
Many Doctors Use Limited Spanish Skills with Patients

Immigrant Health and Cancer Disparities Service Chief Francesca Gany discussed a survey that found that many doctors with limited Spanish-speaking skills continue to discuss medical care with patients without the use of an interpreter. Dr. Gany said it is OK for doctors to use less-advanced language skills to build a rapport with patients, as long as an interpreter is present.

June 13, 2012
Robin Roberts Has MDS. What Is That?

Leukemia Service Chief Martin Tallman talked about myelodysplastic syndrome, a rare blood disorder, after Good Morning America host Robin Roberts announced that she was diagnosed with the disease. Dr. Tallman also discussed the condition in

June 11, 2012
Do You Speak Sunscreen?

Dermatologist Steven Wang explained what the new FDA regulations for sunscreen labels mean.

June 8, 2012
Best Doctors

Seventy-nine Memorial-Sloan Kettering doctors were listed in New York Magazine’s annual Best Doctors issue.

June 5, 2012
Best Children's Hospitals

Memorial Sloan Kettering ranked number 11 among the top 50 pediatric cancer hospitals in U.S. News & World Report’s annual Best Children’s Hospitals issue. The New York Daily News reported on the rankings.

June 5, 2012
The Trouble With ‘Doctor Knows Best’

Epidemiologist and physician Peter Bach authored an essay opining that many doctors will ignore current recommendations to screen for cancer less often and continue to practice as they have been.

June 5, 2012
Childhood Cancer Survivors Face Higher Breast Cancer Risk

Research led by biostatistician Chaya Moskowitz and released at the American Society of Clinical Oncology’s Annual Meeting found that women treated with radiation to the chest for childhood cancer have a high risk of developing breast cancer at a young age – a risk that is comparable to that of women who have mutations in BRCA1 or BRCA2 genes. Coverage appeared in The Wall Street Journal, USA Today, The Associated Press, HealthDay News, and

June 4, 2012
In Study, Drug Delays Worsening of Breast Cancer, with Fewer Side Effects

Breast Cancer Medicine Service Chief Clifford Hudis commented on data released at the American Society of Clinical Oncology’s Annual Meeting that showed that an experimental new drug called TDM-1 delayed the progression of breast cancer with significantly fewer side effects than traditional chemotherapy. Dr. Hudis was also quoted in, and medical oncologist Shanu Modi discussed the data in Bloomberg.

June 3, 2012
Bristol Immune Drug Shows Promise in Three Cancers

Data released at the American Society of Clinical Oncology’s Annual Meeting showed that an experimental new drug, known as an anti-PD-1 treatment, shrunk tumors in patients with several cancers by boosting the body’s own immune system. Immunologist James Allison, whose pioneering work contributed to the first FDA-approved immunotherapy drug ipilimumab (Yervoy™), was quoted. Thoracic Oncology Service Chief Mark Kris also commented on the data in and medical oncologist Jedd Wolchok was quoted in Nature.

June 2, 2012
PSA Test Part of Trend: Fewer Screenings for Well People

Epidemiologist and physician Peter Bach explored the growing concern about overtesting and overtreating patients due to increased recognition of risks and side effects.

May 28, 2012